Advertisement

Secondary prevention in patients with cerebrovascular ischaemic disease

  • P. Prati
  • M. Casaroli
  • C. Vinci
  • I. Pittaro
Satellite Symposium
  • 30 Downloads

Keywords

Clopidogrel Secondary Prevention Ticlopidine Carotid Endarterectomy Carotid Stenosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested reading

  1. Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patient. Antiplatelet Trialists’ Collaboration (1994). BMJ 308:81–106Google Scholar
  2. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterctomy trial collaborators (1991). N Engl J Med 325:445–453.Google Scholar
  3. Dennis M, Bamford J, Sandercock P, Warlow C (1990) Prognosis of transient ischemic attacks in the Oxfordshire community stroke project. Stroke 21:848–853.PubMedGoogle Scholar
  4. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association (1994). Stroke 25(6):1320–1335.Google Scholar
  5. Bots M, van der Wilk EC, Koudstaal PJ, Hofman A, Grobbee DE (1997) Transient neurological attacks in the general population. Prevalence risk factors and clinical relevance. Stroke 28:768–773.PubMedGoogle Scholar
  6. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M (1995) Stroke incidence case fatality and mortality in the WHO MONICA project. Stroke 26:361–367.PubMedGoogle Scholar
  7. Diener H (1997) Antiplatelet drugs in secondary prevention of stroke. Neurology 49[Suppl 4]:75–81.Google Scholar
  8. CAPRIE Steering Committee (1996) A randomised trial of clopidogrel versus aspirin in patient at risk of ischaemic events (CAPRIE). Lancet 348:1329–39.CrossRefGoogle Scholar
  9. Bucher HC, Griffith LE, Guyatt GH (1998) Effect of HMGcoA reductase inhibitors on stroke. Ann Intern Med 128:89–95PubMedGoogle Scholar
  10. Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana, F, Coccheri S (1997) Indobufen versus warfarin in the secondary prevention of major vascular events in monrheumatics atrial fibrillation. Stroke 28(5):1015–1021.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1998

Authors and Affiliations

  • P. Prati
    • 1
  • M. Casaroli
    • 1
  • C. Vinci
    • 1
  • I. Pittaro
    • 1
  1. 1.Neurology DepartmentGervasutta HospitalUdineItaly

Personalised recommendations